Table 1 Summary of reported therapeutic trials for progressive multifocal leukoencephalopathy 123

Sep 22, 2014

10 likes | 131 Views

Table 1 Summary of reported therapeutic trials for progressive multifocal leukoencephalopathy 123. Brew, B. J. et al. (2010) Progressive multifocal leukoencephalopathy and other forms of JC virus disease Nat. Rev. Neurol. doi:10.1038/nrneurol.2010.164.

Share Presentation

Embed Code

Link

neurol
doi 10
1038 nrneurol
reported therapeutic trials
2010 progressive multifocal leukoencephalopathy
progressive multifocal leukoencephalopathy 123

naava

Download Presentation

Table 1 Summary of reported therapeutic trials for progressive multifocal leukoencephalopathy 123

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Table 1 Summary of reported therapeutic trials for progressive multifocal leukoencephalopathy123 Brew, B. J. et al.(2010) Progressive multifocal leukoencephalopathy and other forms of JC virus disease Nat. Rev. Neurol. doi:10.1038/nrneurol.2010.164

Progressive Multifocal Leukoencephalopathy

Progressive Multifocal Leukoencephalopathy. July 31, 2007 Margo Smith, M.D. Department of Medicine Washington Hospital Center. Case 5.

412 views • 17 slides

Progressive Summary

Progressives. 1890 to 1917Progressives were reformers who attempted to solve problems caused by industry, growth of cities and laissez faire.". Progressives were White ProtestantsMiddle class and native born.College Educated Professionals Social workersScholarsPoliticiansPreachersTeacher

384 views • 28 slides

Toxic Leukoencephalopathy

Toxic Leukoencephalopathy. Christopher M. Filley, M.D. B.K. Kleinschmidt-DeMasters, M.D. Douglas K. Novins, M.D. Spero M. Manson, Ph.D. Departments of Neurology, Psychiatry, and Pathology University of Colorado School of Medicine. Background.

595 views • 8 slides

Table 3 Immunotherapy in clinical trials for glioblastoma

Table 3 Immunotherapy in clinical trials for glioblastoma. Tanaka, S. et al . ( 2012) Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.204.

290 views • 1 slides

Figure 2 FLAIR images showing progression of progressive multifocal leukoencephalopathy immune reconstitution inflammat

Figure 2 FLAIR images showing progression of progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome. Brew, B. J. et al. (2010) Progressive multifocal leukoencephalopathy and other forms of JC virus disease Nat. Rev. Neurol. doi:10.1038/nrneurol.2010.164.

156 views • 1 slides

Progressive Multifocal Intraocular Lens G. Rubiolini M.D. Italy grvision

Progressive Multifocal Intraocular Lens G. Rubiolini M.D. Italy www.grvision.com. Disclosure of finanacial interest Author's research is partially funded by Imperial Medical Technologies (Cartersville GA, USA) producing, developing and supplying the product presented . PURPOSE .

252 views • 11 slides

TABLE 11.1 Summary of Casting Processes

TABLE 11.1 Summary of Casting Processes.

514 views • 35 slides

Patient Reported Outcomes in Oncology Trials

Patient Reported Outcomes in Oncology Trials. Virginia Kwitkowski Clinical Reviewer-- FDA Division of Drug Oncology Products Member OND Patient Reported Outcomes Committee CTEP Program Committee Meeting 03/18/09. Objectives. Provide a history of the use of PROs in FDA drug approvals

654 views • 25 slides

Table 1 Current phase III trials of autologous HSCT in SSc

Table 1 Current phase III trials of autologous HSCT in SSc. Tyndall, A. (2011) HSCT for systemic sclerosis—swallows and summers Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2011.136.

132 views • 1 slides

Table 1 Summary of selected potential biomarkers in EGPA

Table 1 Summary of selected potential biomarkers in EGPA. Khoury, P. et al. (2014) Eosinophils in vasculitis: characteristics and roles in pathogenesis Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.98.

142 views • 1 slides

Supplemental Table E: Summary of Results Double-Blind Randomized Controlled Trials of SGA in GAD

Supplemental Table E: Summary of Results Double-Blind Randomized Controlled Trials of SGA in GAD. 1. Meta-Analysis I: Add-on Second-Generation Antipsychotic vs. Placebo in Refractory GAD. 2. Meta-Analysis II: SGA Monotherapy vs. Placebo in GAD. D/C: Discontinuation Mean Diff: Mean difference

181 views • 1 slides

Supplementary Table 1. Clinical summary of SPG21 patients

Supplementary Table 1. Clinical summary of SPG21 patients.

144 views • 7 slides

Summary of ACCORD, ADVANCE, and VADT Trials

Summary of ACCORD, ADVANCE, and VADT Trials. ACCORD - Action to Control Cardiovascular Risk in Diabetes ADVANCE - Action in Diabetes to Prevent Vascular Disease VADT - Veterans Administration Diabetes Trail. Stephen Rith-Najarian, Diabetes Consultant Bemidji Area IHS.

3.19k views • 20 slides

Rare Case of Multicentric Castleman's Disease and Progressive Multifocal Leukoencephalopathy

Rare Case of Multicentric Castleman's Disease and Progressive Multifocal Leukoencephalopathy in a Severely Immunocompromised Patient. Noha Solieman 1 , Sherita N. Chapman 1 , Mohankumar Kurukumbi 1 ,Preema Mehta 2 ,Annapurni Jayam-Trouth

328 views • 1 slides

Table 1 Summary of reported cases of Down syndrome and in utero onset leukemia

Table 1 Summary of reported cases of Down syndrome and in utero onset leukemia. Heald B et al. (2007) Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome Nat Clin Pract Oncol 4 : 433 –438 doi:10.1038/ncponc0876.

119 views • 1 slides

Table 5 Randomized controlled trials of midurethral slings for MUI

Table 5 Randomized controlled trials of midurethral slings for MUI. Cox, A. et al. (2013) Surgical management of female SUI: is there a gold standard? Nat. Rev. Urol. doi:10.1038/nrurol.2012.243.

148 views • 1 slides

Table 1 Summary of studies of primary BAD diagnosed by SeHCAT

Table 1 Summary of studies of primary BAD diagnosed by SeHCAT. Walters, J. R. F. (2014) Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2014.32.

123 views • 1 slides

Table 1 Timing of clinical trials and FDA approval for selected targeted therapies

Table 1 Timing of clinical trials and FDA approval for selected targeted therapies. Maxwell, K. N. & Domchek, S. M. ( 2012) Cancer treatment according to BRCA1 and BRCA2 mutations Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.123.

183 views • 1 slides

Table 1 Ongoing clinical trials of passive Aβ immunotherapies

Table 1 Ongoing clinical trials of passive Aβ immunotherapies. Lemere, C. A. & Masliah, E. (2010) Can Alzheimer disease be prevented by amyloid‑β immunotherapy? Nat. Rev. Neurol. doi:10.1038/nrneurol.2009.219.

124 views • 1 slides

Table 1 Clinical trials on AAV

Table 1 Clinical trials on AAV. Chen, M. & Kallenberg, C. G. M. (2010) ANCA-associated vasculitides—advances in pathogenesis and treatment Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2010.158.

147 views • 1 slides

Progressive Multifocal Leukoencephalopathy Market, Therapeutics Landscape and Pipeline Review H1 2017

Progressive Multifocal Leukoencephalopathy Pipeline Review, H1 2017, provides in depth analysis on therapeutics under development by companies & drug profiles study based on mechanism of action (MoA), route of administration (RoA) and molecule type

72 views • 3 slides

Summary Recommendations In Table Of Contents

A decent-looking table of contents template will give your presentation a professional look. We have created a unique PowerPoint template where you can briefly explain each content in a single page. Download here: https://bit.ly/31Jy3lZ

67 views • 5 slides

More Related